A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Clinical trial NCT05334706 · RECRUITING

Trial details

NCT number: NCT05334706
Sponsor: Miquel Angel Pavon Ribas
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) Infections High-risk HPV HPV-16/ 18

Start date: 2022-09-13
Primary completion: 2026-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.